12 MONTH OUTCOMES OF PACLITAXEL DRUG COATED BALLOON FOR THE TREATMENT OF BULBAR URETHRA STRICTURE. A PROSPECTIVE, NON-RANDOMIZED, OPEN LABEL, MULTI-CENTER CLINICAL STUDY

被引:0
|
作者
Pichardo, M. [1 ]
Gonzalez, C. [1 ]
Fernandez, M. [1 ]
Soriano, D. [1 ]
Virasoro, R. [2 ]
Delong, J. [2 ]
Estrella, R. [3 ]
Rodriguez, R. [4 ]
Espino, G. [5 ]
Elliott, S. [6 ]
机构
[1] Urus, Santo Domingo, Dominican Rep
[2] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[3] Clin Union Med, Santiago De Los Caballer, Dominican Rep
[4] Royal Ctr Panama City, Panama City, Panama
[5] Mi Clin Hosp, Panama City, Panama
[6] Univ Minnesota, Dept Urol, Minneapolis, MN 55455 USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
492
引用
收藏
页码:S370 / S371
页数:2
相关论文
共 50 条
  • [21] PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis-9-Month Angiographic and 12-Month Clinical Results
    Xu, Bo
    Gao, Run-Lin
    Wang, Jian'an
    Yang, Yuejin
    Chen, Shao Liang
    Liu, Bin
    Chen, Fang
    Li, Zhanquan
    Han, Yaling
    Fu, Guosheng
    Zhao, Yelin
    Ge, Junbo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B18 - B18
  • [22] ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
    Kringelbach, Tina
    Hojgaard, Martin
    Rohrberg, Kristoffer
    Spanggaard, Iben
    Laursen, Britt Elmedal
    Ladekarl, Morten
    Haslund, Charlotte Aaquist
    Harslof, Laurine
    Belcaid, Laila
    Gehl, Julie
    Sondergaard, Lise
    Eefsen, Rikke Lovendahl
    Hansen, Karin Holmskov
    Kodahl, Annette Raskov
    Jensen, Lars Henrik
    Holt, Marianne Ingerslev
    Oellegaard, Trine Heide
    Yde, Christina Westmose
    Ahlborn, Lise Barlebo
    Lassen, Ulrik
    BMC CANCER, 2023, 23 (01)
  • [23] ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
    Tina Kringelbach
    Martin Højgaard
    Kristoffer Rohrberg
    Iben Spanggaard
    Britt Elmedal Laursen
    Morten Ladekarl
    Charlotte Aaquist Haslund
    Laurine Harsløf
    Laila Belcaid
    Julie Gehl
    Lise Søndergaard
    Rikke Løvendahl Eefsen
    Karin Holmskov Hansen
    Annette Raskov Kodahl
    Lars Henrik Jensen
    Marianne Ingerslev Holt
    Trine Heide Oellegaard
    Christina Westmose Yde
    Lise Barlebo Ahlborn
    Ulrik Lassen
    BMC Cancer, 23
  • [24] Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care
    Bapsy, Poonamalle Parthasarathy
    Sharan, Bandana
    Kumar, Chaitanya
    Das, Rajeev Patrick
    Rangarajan, Bharath
    Jain, Minish
    Attili, Venkata Sathya Suresh
    Subramanian, Sundaram
    Aggarwal, Shyam
    Srivastava, Mala
    Vaid, Ashok
    CYTOTHERAPY, 2014, 16 (02) : 234 - 244
  • [25] COMPARISON OF INTRALESIONAL HYALURONIC ACID VS. VERAPAMIL FOR THE TREATMENT OF ACUTE PHASE PEYRONIE'S DISEASE: A PROSPECTIVE, OPEN-LABEL NON-RANDOMIZED CLINICAL STUDY
    Cocci, A.
    Di Maida, F.
    Cito, G.
    Campi, R.
    Tellini, R.
    Mari, A.
    Di Mauro, M.
    Falcone, M.
    Capece, M.
    Romano, A.
    Di Costanzo, R.
    Verrienti, P.
    Garaffa, G.
    Mondaini, N.
    Minervini, A.
    Russo, G., I
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S135 - S136
  • [26] Comparison of Intralesional Hyaluronic Acid vs. Verapamil for the Treatment of Acute Phase Peyronie's Disease: A Prospective, Open-Label Non-Randomized Clinical Study
    Cocci, Andrea
    Di Maida, Fabrizio
    Cito, Gianmartin
    Verrienti, Pierangelo
    Laruccia, Nicola
    Campi, Riccardo
    Mari, Andrea
    Di Mauro, Marina
    Falcone, Marco
    Cacciamani, Giovanni E.
    Garaffa, Giulio
    Minervini, Andrea
    Russo, Giorgio Ivan
    WORLD JOURNAL OF MENS HEALTH, 2021, 39 (02): : 352 - 357
  • [27] An open-label, non-randomized, multi-center phase I study evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy of bi-ligand-drug conjugate CBP-1018 in patients with advanced solid tumors
    Li, Kaiwen
    Shi, Yehui
    Wu, Junyan
    Zhou, Liyan
    Ye, Suiwen
    Lai, Xiuping
    Huang, Robert
    Teng, Yan
    Yu, Jiangang
    Chai, Xiaoyan
    Huang, Hai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Cadonilimab in combination with disitamab vedotin or nab-paclitaxel in the treatment of recurrent or metastatic cervical cancer: a prospective, double-cohort, multi-center, open-label, phase II clinical study (AK001)
    Gu, Haifeng
    Zhou, Jian
    Wang, Jianwei
    Liu, Lili
    Zhou, Yun
    Pan, Baoyue
    Ye, Weijun
    Zhou, Li
    Ding, Yan
    Bei, Jinxin
    Cao, Xinping
    Zheng, Min
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A23 - A24
  • [29] A PROSPECTIVE PHASE I/II OPEN LABEL, NON-RANDOMIZED CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AMINOACT MULTI-KINASE INHIBITOR FOR THE ADJUVANT TREATMENT OF DOGS WITH SPONTANEOUSLY OCCURING CANCER
    Ogilvie, G. K.
    Chen, H. Y.
    Mollstedt, O.
    Proulx, D. M.
    Van Horn, L.
    Price, M. D.
    Tsai, M. H.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2011, 25 (03) : 746 - 746
  • [30] Six-Month Outcomes from the Prospective, Multi-Center, Non-Randomized Clinical Study of the COVERA(™) Arterio VeNous (AV) Stent Graft in the Treatment of Stenosis in the VEnous OutfloW of AV Fistula Access Circuits (AVeNEW PAS) (JAN, 10.1007/s00270-024-03930-7 ,2025)
    Dolmatch, Bart
    Saber, Talar
    Underwood, Margo
    AVeNEW PAS trial Investigators, Jonah
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2025, 48 (03) : 422 - 422